The Role of L. plantarum as an Immunomodulator Secretion of Transforming Growth Factor-β1, Transforming Growth Factor-β3, and Interferon-α Macrophages and Dermal Fibroblasts
DOI:
https://doi.org/10.24203/ajas.v5i2.4520Keywords:
L.plantarum, TGFb1, TGFb3, Interferon-alfaAbstract
This research aims to see the effect of L.plantarum in modulating the secretion of Transforming Growth Factor-TGFβ1, TGFβ3 macrophages and fibroblasts, Interferon-IFNα macrophages, and to analyze the possibility of L.plantarum potency in supporting the process of scarless wound healing. The culture of peritoneal macrophages was treated with L.plantarum for 24 hours, while another macrophage was S.aureus stimulated for 6 hours before treatment of L.plantarum for 24 hours. The formed supernatant was separated and centrifuged to serve as a treatment on the culture of rat dermal fibroblasts for 24 hours. The supernatant was then separated and centrifuged; its cytokine level was measured with enzyme-linked immunosorbent assay-ELISA. Treatment of L.plantarum with medium and high doses increased the secretion of IFNa macrophages compared with the control; all L.plantarum doses can stimulate the secretion of TGFβ1 fibroblast and TGFβ3 macrophage significantly, but it does not affect the secretion of TGFβ1 macrophages. It can be concluded that L.plantarum increased the secretion of IFNα macrophages higher than the treatment preceded by S.aureus stimulation. The secretion of TGFβ1 fibroblasts and TGFβ3 fibroblasts also increased, but it was not as high as L.plantarum treatment stimulated by S.aureus. Therefore, the application of L.plantarum to support the process of wound healing, prophylactic of the excessive scar and fibrosis can be researched further.
References
G. Caramia, A. Atzei, and V. Fanos, “Probiotics and the skin,†Clin. Dermatol., vol. 26, no. 1, pp. 4–11, 2008.
M. Colonna, “TLR pathways and IFN-regulatory factors: To each its own,†Eur. J. Immunol., vol. 37, no. 2, pp. 306–309, 2007.
M. Miettinen et al., “Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages © 2012 Landes Bioscience . Do not distribute,†vol. 3, no. 6, pp. 510–522, 2012.
E. Savilahti, “Probiotics in the Treatment and Prevention of Allergies in Children,†Biosci. Microflora, vol. 30, no. 4, 2016.
S. Barrientos, O. Stojadinovic, M. S. Golinko, H. Brem, and M. Tomic-Canic, “Growth factors and cytokines in wound healing,†Wound Repair Regen., vol. 16, no. 5, pp. 585–601, 2008.
L. Satish and S. Kathju, “Cellular and molecular characteristics of scarless versus fibrotic wound healing,†Dermatol. Res. Pract., vol. 2010, no. 1, 2010.
J. W. Penn, A. O. Grobbelaar, and K. J. Rolfe, “The role of the TGF-β family in wound healing, burns and scarring: a review.,†Int. J. Burns Trauma, vol. 2, no. 1, pp. 18–28, 2012.
M. Taglietti, C. N. Hawkins, and J. Rao, “Novel topical drug delivery systems and their potential use in acne vulgaris.,†Skin Therapy Lett., vol. 13, no. 5, pp. 6–8, 2008.
G. D. Kalliolias and L. B. Ivashkiv, “Overview of the biology of type I interferons.,†Arthritis Res. Ther., vol. 12, no. Suppl 1, pp. 1–9, 2010.
J. Bekisz, S. Baron, C. Balinsky, A. Morrow, and K. C. Zoon, “Antiproliferative properties of type I and type II interferon,†Pharmaceuticals, vol. 3, no. 4, pp. 994–1015, 2010.
S. Lebeer, J. Vanderleyden, and S. C. J. De Keersmaecker, “Genes and Molecules of Lactobacilli Supporting Probiotic Action,†vol. 72, no. 4, pp. 728–764, 2008.
M. P. Rodero and K. Khosrotehrani, “Skin wound healing modulation by macrophages,†Int. J. Clin. Exp. Pathol., vol. 3, no. 7, pp. 643–653, 2010.
P. van Baarlen et al., “Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways.,†Proc. Natl. Acad. Sci. U. S. A., vol. 108 Suppl, pp. 4562–4569, 2011.
G. Trinchieri, “Type I interferon: friend or foe?,†J. Exp. Med., 2010.
S. Lebeer, I. J. J. Claes, and J. Vanderleyden, “Anti-inflammatory potential of probiotics: Lipoteichoic acid makes a difference,†Trends Microbiol., vol. 20, no. 1, pp. 5–10, 2012.
D. R. Tobergte and S. Curtis, “Culture of animal cell 5th,†J. Chem. Inf. Model., vol. 53, no. 9, pp. 1689–1699, 2013.
Y. Haileselassie et al., “Lactobacilli Regulate Staphylococcus aureus 161:2-Induced Pro-Inflammatory T-Cell Responses In Vitro,†PLoS One, vol. 8, no. 10, pp. 1–12, 2013.
H. F. Huseini, G. Rahimzadeh, M. R. Fazeli, M. Mehrazma, and M. Salehi, “Evaluation of wound healing activities of kefir products,†Burns, vol. 38, no. 5, pp. 719–723, 2012.
Heydari Nasrabadi, “Study of cutaneous wound healing in rats treated with Lactobacillus plantarum on days 1, 3, 7, 14 and 21,†African J. Pharm. Pharmacol., vol. 5, no. 21, pp. 2395–2401, 2011.
S. Werner and R. Grose, “Regulation of wound healing by growth factors and cytokines.,†Physiol. Rev., vol. 83, no. 3, pp. 835–870, 2003.
T. J. Koh and L. A. DiPietro, “Inflammation and wound healing: the role of the macrophage.,†Expert Rev. Mol. Med., vol. 13, no. July, p. e23, 2011.
C. Wang et al., “Characterization of murine macrophages from bone marrow, spleen and peritoneum,†BMC Immunol., vol. 14, no. 1, p. 6, 2013.
S. Van Linthout, K. Miteva, and C. Tsch??pe, “Crosstalk between fibroblasts and inflammatory cells,†Cardiovasc. Res., vol. 102, no. 2, pp. 258–269, 2014.
R. Kaji, J. Kiyoshima-Shibata, M. Nagaoka, M. Nanno, and K. Shida, “Bacterial Teichoic Acids Reverse Predominant IL-12 Production Induced by Certain Lactobacillus Strains into Predominant IL-10 Production via TLR2-Dependent ERK Activation in Macrophages,†J. Immunol., vol. 184, no. 7, pp. 3505–3513, 2010.
N. Yanase, M. Hayashida, Y. Kanetaka-Naka, A. Hoshika, and J. Mizuguchi, “PKC-δ mediates interferon-α-induced apoptosis through c-Jun NH2-terminal kinase activation,†BMC Cell Biol., vol. 13, no. 1, p. 7, 2012.
M. Stawowczyk, S. Van Scoy, K. P. Kumar, and N. C. Reich, “The interferon stimulated gene 54 promotes apoptosis,†J. Biol. Chem., vol. 286, no. 9, pp. 7257–7266, 2011.
N. Bouladoux et al., “Regulatory role of suppressive motifs from commensal DNA,†Mucosal Immunol., vol. 5, no. 6, pp. 623–634, 2012.
E. Bolesta et al., “This information is current as of November 11, 2010,†J. Immunol., 2010.
H. Nasrabadi and T. Ebrahimi, “Comparison of the effects of Lactobacillus brevis and Lactobacillus plantarum on cutaneous wound healing in rats,†African J. Microbiol. Res., vol. 5, no. 24, pp. 4226–4233, 2011.
Downloads
Published
Issue
Section
License
- Papers must be submitted on the understanding that they have not been published elsewhere (except in the form of an abstract or as part of a published lecture, review, or thesis) and are not currently under consideration by another journal published by any other publisher.
- It is also the authors responsibility to ensure that the articles emanating from a particular source are submitted with the necessary approval.
- The authors warrant that the paper is original and that he/she is the author of the paper, except for material that is clearly identified as to its original source, with permission notices from the copyright owners where required.
- The authors ensure that all the references carefully and they are accurate in the text as well as in the list of references (and vice versa).
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.
